Law360 (March 26, 2020, 1:07 PM EDT) -- Despite testimony from a former Ariad Pharmaceuticals executive that may have crossed the line, the First Circuit on Wednesday upheld her ex-husband's conviction for trading on insider company information.
The appellate panel acknowledged that Maureen Curran, the company’s senior drug safety executive at the time, may have overstepped when she suggested her then-husband, Harold Altvater, was a bad spouse willing to ruin their marriage in the name of scoring some quick cash off of Ariad stock trades.
But the First Circuit ruled that the testimony was outweighed by a wealth of evidence demonstrating that Altvater dumped Ariad shares after Curran told...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!